Login
← Go Back
Piramal Pharma
PPLPHARMA · Pharma > Pharmaceuticals & Drugs Listing date: Oct. 19, 2022
Stock Price vs Company Growth
1d
1.9%
1w
4.8%
1m
14.3%
3m
31.9%
6m
64.6%
1y
106.7%
all
13.9%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 246 1.9%
182
308
Company Overview
Sales
8,704 Cr
Growth: 12.4%
Profit after Tax
45.3 Cr
Growth: 63.3%
Large Cap
32,607 Cr
P/E: 702.7x
Industry P/E: 35.6x
Fundamentals
Sales (Cr) ₹ 8,704
Growth 12.4%
EBITDA 15.4%
P/S 3.7x
Dividend 0.0%
P/E 702.7x
Book Value ₹ 59.2
PEG Ratio 56.5x
ROE 0.6%
P/B 4.2x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company offers a portfolio of differentiated products and services through end-to-end manufacturing capabilities across many global facilities and a global distribution network in hundreds of countries. It includes PPS, PCC and the India Consumer Healthcare business, selling over-the-counter products.
Belongs to (17 Indices) view more
Investors (5)
an.sujay
chethan3
ravi_kum...